‘Ohana Health Plan and Hope Services Hawaii Launch Residential Program for Integrated Clinical Care


admin

‘Ohana Health Plan, a leading provider of government-sponsored managed care services in Hawaii and a Centene Corporation company (NYSE: CNC), in partnership with Hope Services Hawaii, Hawaii Island’s largest nonprofit homeless services provider, held a grand opening and blessing for a brand-new residential program for integrated clinical care. The program […]

Acxiom and DeepIntent Introduce Direct Data Integration to Optimize Healthcare Marketing Reach, Impact, and Performance


admin

Acxiom, the global leader in customer intelligence, today announced its strategic integration with DeepIntent, the healthcare advertising platform. Healthcare brands, marketers, and agencies can use DeepIntent’s Demand Side Platform (DSP) to directly access Acxiom’s exclusive health interest audiences, detailed, HIPAA-compliant health-related interest data, and advanced analytics, increasing healthcare interest marketing […]

THREAD and Amazon Web Services Modernize Clinical Research with Launch of Cloud-based, AI-driven Decentralized Clinical Trials Technology


Hitesh

THREAD®, the leading technology and consulting service provider enabling electronic clinical outcome assessments (eCOA) and decentralized clinical trials (DCTs), announced today that it is collaborating with Amazon Web Services, Inc. (AWS) to launch enhancements to the THREAD platform powered by enterprise-scale automation and built-in AI-driven technologies. Read More

Jazz Pharmaceuticals Announces Agreement to Divest Sunosi® (solriamfetol) to Axsome Therapeutics


Hitesh

Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that it has entered into a definitive agreement to divest Sunosi® (solriamfetol), a dual-acting dopamine and norepinephrine reuptake inhibitor shown to improve wakefulness in adults living with excessive daytime sleepiness (EDS) due to narcolepsy or obstructive sleep apnea (OSA), to Axsome Therapeutics (Nasdaq: […]

Innovent and Lilly Expand Strategic Partnership in Oncology


Hitesh

Innovent Biologics, Inc. (“Innovent”, HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of cancer, metabolic, autoimmune and other major diseases, and Eli Lilly and Company (“Lilly”,NYSE: LLY) today announced that in light of both parties’ shared commitment to continue bringing innovative medicines […]